These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients. Kiayias JA; Vlachou ED; Theodosopoulou E; Lakka-Papadodima E Diabetes Care; 2002 Jul; 25(7):1251-2. PubMed ID: 12087036 [No Abstract] [Full Text] [Related]
6. New insights into the older hypoglycemic agents in type 2 diabetes therapy. Cao M; Bloomgarden Z J Diabetes; 2020 Nov; 12(11):844-847. PubMed ID: 32767624 [No Abstract] [Full Text] [Related]
7. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes. Garber A; Marre M; Blonde L; Allavoine T; Howlett H; Lehert P; Cornes M Diabetes Obes Metab; 2003 May; 5(3):171-9. PubMed ID: 12681024 [TBL] [Abstract][Full Text] [Related]
8. When metformin fails in type 2 diabetes mellitus. Esposito K; Bellastella G; Giugliano D Arch Intern Med; 2011 Feb; 171(4):365-6. PubMed ID: 21357815 [No Abstract] [Full Text] [Related]
9. Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents. Vinik AI; Cincotta AH; Scranton RE; Bohannon N; Ezrokhi M; Gaziano JM Endocr Pract; 2012; 18(6):931-43. PubMed ID: 23186965 [TBL] [Abstract][Full Text] [Related]
10. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes]. Menéndez Torre E; Lafita Tejedor FJ; Artola Menéndez S; Millán Núñez-Cortés J; Alonso García A; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R; Aten Primaria; 2011 Apr; 43(4):202.e1-9. PubMed ID: 21382648 [No Abstract] [Full Text] [Related]
11. Glycaemic control in diabetes. Herman W Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678 [No Abstract] [Full Text] [Related]
12. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes]. Menéndez Torre E; Lafita Tejedor J; Artola Menéndez S; Millán Núñez-Cortés J; Alonso García A; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R; Rev Clin Esp; 2011 Mar; 211(3):147-55. PubMed ID: 21376312 [No Abstract] [Full Text] [Related]
13. [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes]. Menéndez Torre E; Lafita Tejedor FJ; Artola Menéndez S; Millán Núñez-Cortés J; Alonso García Á; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R; Endocrinol Nutr; 2011 Mar; 58(3):112-20. PubMed ID: 21354873 [No Abstract] [Full Text] [Related]
14. [ADOPT study: Reevaluation of antidiabetic drugs. Control of diabetes]. MMW Fortschr Med; 2007 Apr; 149(15):52-3. PubMed ID: 17668778 [No Abstract] [Full Text] [Related]
15. Management of Type 2 Diabetes in 2017: Getting to Goal. Reusch JE; Manson JE JAMA; 2017 Mar; 317(10):1015-1016. PubMed ID: 28249081 [No Abstract] [Full Text] [Related]
16. Recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes. Consensus document. Menéndez Torre E; Lafita Tejedor J; Artola Menéndez S; Milán Núñez-Cortés J; Alonso García A; Puig Domingo M; García Solans JR; Alvarez Guisasola F; García Alegría J; Mediavilla Bravo J; Miranda Fernández-Santos C; Romero González R; ; ; ; ; ; ; ; ; ; Nefrologia; 2011; 31(1):17-26. PubMed ID: 21270909 [No Abstract] [Full Text] [Related]
17. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin. Blonde L; Sandberg MI; Guthrie RD Diabetes Care; 1999 Jun; 22(6):1004-6. PubMed ID: 10372262 [No Abstract] [Full Text] [Related]